• main

PharmNovo combines smart chemistry and bioscience to discover new medicines to treat diseases of the nervous system
PharmNovo blends academic and industrial expertise to bring safe and effective medicines to the marketplace
Development of novel receptor agonists and antagonists to treat chronic pain and related CNS disorders
Feel free to Contact us
29 November, 2015

Pharmnovo have moved office/conference to Hönö and Pharmnovo UK Ltd has got new office/laboratories in Liverpool. The old conference is still in place in Gothenburg , Södra vägen 25.

Read more
8 October, 2015

David Kendall and Bengt von Mentzer gave the first public presentations of PN6047, PharmNovo’s biased delta opioid receptor agonist, at the European Neuropeptide Conference in Aberdeen (28th September-1st October). Their descriptions of the molecular mechanisms and in vivo effects of the compound generated a good deal of interest from the knowledgeable audience of academics and…

Read more